182 related articles for article (PubMed ID: 34095320)
1. DGAT1 Expression Promotes Ovarian Cancer Progression and Is Associated with Poor Prognosis.
Xia L; Wang Y; Cai S; Xu M
J Immunol Res; 2021; 2021():6636791. PubMed ID: 34095320
[TBL] [Abstract][Full Text] [Related]
2. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/Smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
4. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
Mitra R; Le TT; Gorjala P; Goodman OB
BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer.
He P; Cheng S; Hu F; Ma Z; Xia Y
BMC Cancer; 2021 Mar; 21(1):252. PubMed ID: 33750350
[TBL] [Abstract][Full Text] [Related]
6. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
8. p38MAPK family isoform p38α and activating transcription factor 2 are associated with the malignant phenotypes and poor prognosis of patients with ovarian adenocarcinoma.
Song WJ; Dong Y; Luo C; Chen YY
Pathol Res Pract; 2017 Oct; 213(10):1282-1288. PubMed ID: 28916425
[TBL] [Abstract][Full Text] [Related]
9. Topological orientation of acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) and identification of a putative active site histidine and the role of the n terminus in dimer/tetramer formation.
McFie PJ; Stone SL; Banman SL; Stone SJ
J Biol Chem; 2010 Nov; 285(48):37377-87. PubMed ID: 20876538
[TBL] [Abstract][Full Text] [Related]
10. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
[TBL] [Abstract][Full Text] [Related]
11. Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients.
Sinha D; Chong L; George J; Schlüter H; Mönchgesang S; Mills S; Li J; Parish C; Bowtell D; Kaur P;
Clin Cancer Res; 2016 Apr; 22(7):1813-24. PubMed ID: 26589433
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
13. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
15. Prolonged silencing of diacylglycerol acyltransferase-1 induces a dedifferentiated phenotype in human liver cells.
Chang S; Sung PS; Lee J; Park J; Shin EC; Choi C
J Cell Mol Med; 2016 Jan; 20(1):38-47. PubMed ID: 26493024
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of RALYL suppresses the progression of ovarian clear cell carcinoma through inhibiting MAPK and CDH1 signaling pathways.
Xia Y; Ye S; Yang Y; Liu Y; Tong G
Int J Med Sci; 2021; 18(3):785-791. PubMed ID: 33437214
[No Abstract] [Full Text] [Related]
17. The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications.
Deng B; Kong W; Shen X; Han C; Zhao Z; Chen S; Zhou C; Bae-Jump V
J Transl Med; 2024 Mar; 22(1):290. PubMed ID: 38500157
[TBL] [Abstract][Full Text] [Related]
18. Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.
Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Zhang W; Xu P; Mao G
J Mol Histol; 2016 Feb; 47(1):47-57. PubMed ID: 26644004
[TBL] [Abstract][Full Text] [Related]
19. High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.
Xi J; Zeng ST; Guo L; Feng J
Cancer Invest; 2016; 34(3):130-6. PubMed ID: 26962950
[TBL] [Abstract][Full Text] [Related]
20. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
